2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$2.70-$0.005 (-0.19%)
Price as of Jun 03, 2026 7:11 PM EDT- $609.1MMarket Cap
- 87.50%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$2.70-$0.005 (-0.19%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 206.1M +2.39% | 201.3M +7.78% | 186.8M -0.81% | 188.3M +18.05% | |
Cost of Revenue | 93.8M +16.22% | 80.7M +15.41% | 70.0M -6.65% | 75.0M +18.08% | |
Gross Profit | 112.3M +12.83% | 99.5M +15.19% | 86.4M -0.80% | 87.1M +29.25% | |
Sales and Marketing Expense | 80.9M +6.62% | 75.9M +0.50% | 75.5M -9.38% | 83.3M +2.52% | |
Research and Development Expense | -67.7M +14.96% | -58.9M -12.91% | -67.6M +5.51% | -64.1M +0.65% | |
Depreciation and Amortization Expense | 1.4M -23.13% | 1.9M -28.63% | 2.6M -12.90% | 3.0M -5.21% | |
Total Operating Expenses | 148.6M +10.26% | 134.8M -8.23% | 146.9M -0.38% | 147.4M +1.70% | |
Operating Profit | -8.7M -38.97% | -14.2M -52.67% | -30.1M -11.82% | -34.1M -30.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -8.4M +43.82% | -5.8M +18.44% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -8.4M +43.82% | -5.8M +18.44% | |
Total Nonoperating Income and Expense | -6.6M +1.09% | -6.5M -10.15% | -7.3M -11.95% | -8.3M +61.22% | |
Income before Taxes | -15.3M -26.37% | -20.8M -44.39% | -37.3M -11.85% | -42.3M -21.68% | |
Income Taxes | 354,000 +72.68% | 205,000 -36.92% | 325,000 -33.40% | 488,000 +52.98% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -15.6M -25.29% | -20.9M -44.20% | -37.5M -12.37% | -42.8M -21.32% | |
Net Income from Continuing Operations Applicable to Common | -15.3M -26.37% | -20.8M -44.39% | -37.3M -11.85% | -42.3M -21.68% | |
Basic EPS and Net Income | -0.08 -27.27% | -0.11 -47.62% | -0.21 -12.50% | -0.24 -25.00% | |
Diluted EPS and Net Income | -0.08 -27.27% | -0.11 -47.62% | -0.21 -12.50% | -0.24 -25.00% | |
Basic Weighted Average Shares | 190.6M +3.27% | 184.6M +2.38% | 180.3M +2.11% | 176.5M +3.07% | |
Diluted Weighted Average Shares | 190.6M +3.27% | 184.6M +2.38% | 180.3M +2.11% | 176.5M +3.07% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.0M -1.50% | 20.3M +74.00% | 11.6M -67.27% | 35.6M -27.02% | |
Short-Term Investments | 62.9M +4.54% | 60.2M +11.03% | 54.2M -18.57% | 66.6M -17.41% | |
Cash and Cash Equivalents and Short-Term Investments | 82.9M +3.02% | 80.5M +22.17% | 65.9M -35.54% | 102.2M -21.03% | |
Total Current Assets | 174.4M +14.71% | 152.0M +5.25% | 144.4M -15.11% | 170.1M -9.06% | |
Accumulated Depreciation | 19.7M +6.69% | 18.4M +11.94% | 16.5M +15.87% | 14.2M +19.97% | |
Property and Plant and Equipment and Net | 9.2M +28.66% | 7.2M -17.20% | 8.6M -21.23% | 11.0M -10.15% | |
Total Long-Term Assets | 11.0M -34.24% | 16.8M +47.05% | 11.4M -46.56% | 21.4M -1.11% | |
Total Assets | 221.9M +10.42% | 200.9M +1.60% | 197.7M -9.33% | 218.1M -8.17% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 43.3M +124.61% | 19.3M -3.51% | 20.0M -64.39% | 56.2M +282.11% | |
Total Current Liabilities | 100.8M +58.47% | 63.6M -5.80% | 67.5M -42.32% | 117.1M +49.01% | |
Total Long-Term Debt | 40.5M -37.49% | 64.9M +8.47% | 59.8M +338.26% | 13.6M -75.07% | |
Total Long-Term Liabilities | 5.4M +38.76% | 3.9M +20.15% | 3.2M -7.52% | 3.5M +49.40% | |
Total Liabilities | 156.9M +8.94% | 144.0M -0.20% | 144.3M -3.49% | 149.5M -1.55% | |
Retained Earnings | -1.1B +1.47% | -1.1B +2.00% | -1.0B +3.72% | -1.0B +4.44% | |
Total Stockholders Equity | 64.2M +14.39% | 56.1M +6.64% | 52.6M -22.13% | 67.6M -20.10% | |
Total Shares Outstanding | 192.1M +3.43% | 185.8M +2.49% | 181.2M +2.06% | 177.6M +2.25% | |
Cash Flow | |||||
Cash from Operating Activities | 4.8M -57.42% | 11.4M +126.31% | -43.2M +68.53% | -25.6M -24.49% | |
Capital Expenditures | 3.7M +31.44% | 2.8M -38.29% | 4.6M +129.85% | 2.0M +119.78% | |
Cash from Investing Activities | -6.2M -24.17% | -8.1M -194.27% | 8.6M +1.89% | 8.5M -33.29% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 231,000 -95.35% | 5.0M -53.49% | 10.7M +154.60% | 4.2M -87.78% | |
Financials Ratio | |||||
Gross Margin | 54.47% -9.05% | 59.89% -4.24% | 62.54% +3.90% | 60.20% -0.02% | |
Operating Margin | -4.21% -40.40% | -7.07% -56.08% | -16.09% -11.10% | -18.10% -41.01% | |
Return on Assets | -7.39% -29.55% | -10.49% -41.80% | -18.03% -3.99% | -18.78% -20.75% | |
Return on Equity | -25.97% -32.48% | -38.45% -38.32% | -62.35% +10.93% | -56.20% -2.62% | |
Revenue Growth | 2.39% -69.26% | 7.78% +1,064.56% | -0.81% -104.47% | 18.05% -54.44% | |
Current Ratio | 1.73 -27.62% | 2.39 +11.72% | 2.14 +47.18% | 1.45 -38.97% | |
Cash Ratio | 0.20 -37.85% | 0.32 +84.70% | 0.17 -43.26% | 0.30 -51.02% | |
Debt-to-Equity Ratio | 1.31 -12.86% | 1.50 -1.10% | 1.52 +46.80% | 1.03 +25.84% | |
Debt-to-Assets Ratio | 0.38 -9.74% | 0.42 +3.82% | 0.40 +26.05% | 0.32 +9.51% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow